Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01371903 · ClinicalTrials.gov registry record
The Effects of Patient Features on Opioid Induced End-Tidal CO2
A clinical trial, sponsored by Albany Medical College.
- Completed
- Registry status
- 278
- Enrollment target
NCT01371903: Completed study, sponsored by Albany Medical College.
NCT01371903 is a clinical trial that has completed, run by Albany Medical College. The registered enrollment target is 278 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01371903 has completed, sponsored by Albany Medical College.
- COMPLETED
- Registry status
- 278 participants
- Enrollment target
Study Summary
Emergency department patients receiving opioid pain medicine such as morphine, fentanyl or Dilaudid are eligible. After medication exhaled carbon dioxide is measured. and recorded.
Primary Outcome
measured through small nasal cannula (plastic tube at base of nares)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 278 participants |
| Start Date | 2010-08 |
| Est. Completion | 2012-11 |
What the finished NCT01371903 record still lists
NCT01371903 is an observational study that tracks outcomes without assigning an intervention. The registered 278 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01371903 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01371903 about?
NCT01371903 is a clinical study titled "The Effects of Patient Features on Opioid Induced End-Tidal CO2". Emergency department patients receiving opioid pain medicine such as morphine, fentanyl or Dilaudid are eligible. After medication exhaled carbon dioxide is measured. and recorded.
What is the current status of trial NCT01371903?
This trial is currently completed. The enrollment target is 278 participants. The study started on 2010-08. Estimated completion is 2012-11.
Who is sponsoring clinical trial NCT01371903?
This trial is sponsored by Albany Medical College, which has 52 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04586959 · 278 participants · NA
Uterine Manipulation During Minimally Invasive Surgery for Early Stage Endometrial Cancer
- NCT05010148 · 278 participants · Phase 3
A Clinical Trial of Intravenous Lidocaine After Spinal Surgery to Prevent Delirium and Reduce Pain
- NCT05489237 · 278 participants · Phase 1
First-in-human Study of IDRX-42 in Participants With Metastatic and/or Unresectable Gastrointestinal Stromal Tumors
- NCT05965245 · 278 participants · NA
Suubi-Mhealth: A Mobile Health Intervention to Address Depression Among Youth
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia